News
GNNSF
5.70
+4.59%
0.25
Weekly Report: what happened at GNNSF last week (0928-1002)?
Weekly Report · 19h ago
Weekly Report: what happened at GNNSF last week (0921-0925)?
Weekly Report · 09/28 10:13
Weekly Report: what happened at GNNSF last week (0914-0918)?
Weekly Report · 09/21 10:13
Genscript Biotech Halves Trading Lot Size to Boost Liquidity on Hong Kong Market
TipRanks · 09/21 09:39
CSC Financial Sticks to Its Buy Rating for Genscript Biotech (GNNSF)
TipRanks · 09/18 08:25
Analysts Are Bullish on Top Healthcare Stocks: LifeMD (LFMD), Genscript Biotech (GNNSF)
TipRanks · 09/17 16:00
Genscript Biotech Joins Lilly’s AI Drug Discovery Platform Amid Share Price Surge
TipRanks · 09/17 15:08
Genscript Biotech Reshapes Board Committees After Director’s Passing
TipRanks · 09/16 08:38
Genscript Biotech Details Board and Committee Structure in Governance Update
TipRanks · 09/16 08:37
Genscript Biotech Raises HK$2.33 Billion Through Hong Kong Share Placing
TipRanks · 09/15 12:07
Weekly Report: what happened at GNNSF last week (0907-0911)?
Weekly Report · 09/14 10:18
Genscript Biotech to Raise HK$2.33 Billion via Discounted Share Placing for AIDD Expansion
TipRanks · 09/10 23:38
Weekly Report: what happened at GNNSF last week (0831-0904)?
Weekly Report · 09/07 10:12
GenScript Biotech Updates Cayman Islands Corporate Service Provider Names
TipRanks · 09/07 08:38
Genscript Plans Hong Kong Spin-Off Listing for Probio Technology
TipRanks · 09/04 00:38
Weekly Report: what happened at GNNSF last week (0824-0828)?
Weekly Report · 08/31 10:19
Weekly Report: what happened at GNNSF last week (0817-0821)?
Weekly Report · 08/24 10:19
Guotai Haitong Keeps Their Buy Rating on Genscript Biotech (GNNSF)
TipRanks · 08/21 08:55
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Genscript Biotech (OtherGNNSF) and Cochlear (OtherCHEOF)
TipRanks · 08/20 12:20
CSC Financial Reaffirms Their Buy Rating on Genscript Biotech (GNNSF)
TipRanks · 08/20 05:26
More
Webull provides a variety of real-time GNNSF stock news. You can receive the latest news about Genscript Biotec through multiple platforms. This information may help you make smarter investment decisions.
About GNNSF
Genscript Biotech Corp is an investment holding company principally engaged in the manufacture and sale of life science research products and services. The Company operates its businesses through five segments. The Life-science Services and Products segment provides comprehensive research services and products. The Biologics Development Services segment provides comprehensive services to help biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene, cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment provides industrial enzyme development and production through non-pathogenic microbial strains constructed using genetic engineering. The Cell Therapy segment discovers and develops CAR-T therapies for the treatment of liquid and solid tumors. The Operation segment provides shared services to other segments. The Company mainly operates its businesses in the domestic and overseas markets.